Australia markets closed

Getein Biotech, Inc (603387.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
9.71-0.22 (-2.22%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,306,429
1,369,162
1,821,861
1,401,701
1,123,336
Cost of revenue
428,726
446,065
636,392
482,461
415,297
Gross profit
877,703
923,097
1,185,468
919,240
708,039
Operating expenses
Research development
206,831
217,992
223,222
163,393
119,068
Selling general and administrative
366,034
375,004
338,179
263,478
208,687
Total operating expenses
639,067
654,815
630,419
482,911
360,757
Operating income or loss
238,635
268,282
555,050
436,329
347,282
Interest expense
13,676
16,943
16,607
14,312
6,222
Income before tax
267,480
304,942
559,979
451,633
374,040
Income tax expense
20,334
20,861
56,034
39,622
43,727
Income from continuing operations
247,146
284,080
503,945
412,011
330,313
Net income
244,259
279,772
498,910
398,990
304,733
Net income available to common shareholders
244,259
279,772
498,910
398,990
304,733
Basic EPS
0.50
0.55
0.98
0.79
0.60
Diluted EPS
0.50
0.55
0.98
0.78
0.60
Basic average shares
507,649
508,676
509,092
505,051
507,889
Diluted average shares
507,649
508,676
509,092
511,526
507,889